4/A//SEC Filing
Wagoner Dayne 4/A
Accession 0000914062-07-000269
CIK 0001072313other
Filed
May 24, 8:00 PM ET
Accepted
May 25, 5:41 PM ET
Size
15.2 KB
Accession
0000914062-07-000269
Insider Transaction Report
Form 4/AAmended
AURIGA LABORATORIES, INC.ARGA.OB
Wagoner Dayne
Director
Transactions
- Sale
Common Stock
2007-05-22$1.15/sh−440$506→ 352,642 total - Sale
Common Stock
2007-05-22$1.02/sh−1,280$1,306→ 357,152 total - Sale
Common Stock
2007-05-22$1.03/sh−110$113→ 357,042 total - Sale
Common Stock
2007-05-22$1.05/sh−2,310$2,426→ 354,732 total - Sale
Common Stock
2007-05-22$1.10/sh−770$847→ 353,082 total - Sale
Common Stock
2007-05-22$1.09/sh−220$240→ 353,852 total - Sale
Common Stock
2007-05-22$1.08/sh−660$713→ 354,072 total
Holdings
- 2,355,949(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on September 18, 2006.
Documents
Issuer
AURIGA LABORATORIES, INC.
CIK 0001072313
Entity typeother
Related Parties
1- filerCIK 0001363481
Filing Metadata
- Form type
- 4/A
- Filed
- May 24, 8:00 PM ET
- Accepted
- May 25, 5:41 PM ET
- Size
- 15.2 KB